4.530USD+4.530After-hours 07/31, 20:00 (ET)
265.66MMarket Cap
LossP/E TTM
Foghorn Therapeutics Inc.
FHTX Balance Sheet
You can check out the annual or quarterly balance sheets of Foghorn Therapeutics Inc. here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing FHTX stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Foghorn Therapeutics Inc. Have?
In its most recent quarterly, Foghorn Therapeutics Inc. had 87.66M in cash and cash equivalents.
How Much Are Foghorn Therapeutics Inc.'s Total Liabilities?
Foghorn Therapeutics Inc. reported 306.60M in total liabilities as of the latest reported quarter, including 59.74M in current liabilities and 246.87M in non-current liabilities.
What Are Foghorn Therapeutics Inc.'s Total Assets?
As of the latest reported quarter, Foghorn Therapeutics Inc.'s total assets were 198.10M, consisting of 163.24M in current assets and 34.87M in non-current assets.
How Much Shareholders' Equity Does Foghorn Therapeutics Inc. Have?
Foghorn Therapeutics Inc. reported -108.50M in total shareholders' equity as of the latest reported quarter.